Comparative Effects of BBT and Active Cycle of Breathing Technique on Dyspnea and Quality of Life in COPD

NCT05947253 | Unknown DMC

• 1 other identifier: REC/RCR & AHS/22/0318
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

Comparative effects of Butyeko breathing technique and Active Cycle of Breathing technique on dyspnea and quality of life in patients with chronic obstructive pulmonary disease

Conditions

COPD

Keywords

Buteyko breathing technique

Outcome Measures

Primary Outcomes (2)

• Borg's dyspnea scale.

  For the measurement of dyspnea The Modified Borg Dyspnea Scale (MBS) is a 0 to 10 rated numerical score used to measure dyspnea as reported by the patient during submaximal exercise and is routinely administered during six-minute walk testing (6MWT

  4 weeks

• Spirometry

  Spirometry is the most common of the pulmonary function tests. It measures lung function, specifically the amount and/or speed of air that can be inhaled and exhaled. Spirometry is helpful in assessing breathing patterns that identify conditions such as asthma, Chronic obstructive pulmonary disease

  4 weeks

Study Arms (2)

BUTYEKO BREATHING TECHNIQUE

EXPERIMENTAL

First Group A 20 participants received Buyteko breathing technique while will be given 5 days per week

Other: Buyteko breathing technique

active cycle of breathing technique

EXPERIMENTAL

Group B 20 participants received active cycle of breathing technique and session of 35min will be given 5 days per week

Other: active cycle of breathing technique

Interventions

Buyteko breathing technique OTHER

group A 20 participants received Buyteko breathing technique 2 session for 3 weeks

BUTYEKO BREATHING TECHNIQUE

active cycle of breathing technique OTHER

Group B 20 participants received active cycle of breathing technique 2 session for 3 weeks

active cycle of breathing technique

Eligibility Criteria

• Age: 50 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Clinical diagnosis of COPD confirmed by smoking history.
• PFT showing irreversible airflow limitation.
• Patients hemodynamically stable.
• Males and females.
• Patients capable of completing IPAQ questionnaire

You may not qualify if:

• Evidence of unstable cardiac disease, Pulmonale decompensation
• Disabling diseases which prevented participation in the exercise program, such as orthopedic inabilities or peripheral vascular disease.
• Systemic illness.
• Resting O2 saturation \<90% with room air breathing and Patient with viral infection

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

Pulmonary ward Jinnah hospital Lahore.

Lahore, Punjab Province, 54000, Pakistan

RECRUITING

Related Publications (6)

• Vogelmeier CF, Roman-Rodriguez M, Singh D, Han MK, Rodriguez-Roisin R, Ferguson GT. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020 May;166:105938. doi: 10.1016/j.rmed.2020.105938. Epub 2020 Mar 21.

  PMID: 32250871 BACKGROUND

• May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015 Jan-Feb;36(1):4-10. doi: 10.2500/aap.2015.36.3812.

  PMID: 25562549 BACKGROUND

• Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006 Sep;3(7):619-23. doi: 10.1513/pats.200603-093SS.

  PMID: 16963544 BACKGROUND

• Fazleen A, Wilkinson T. Early COPD: current evidence for diagnosis and management. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620942128. doi: 10.1177/1753466620942128.

  PMID: 32664818 BACKGROUND

• Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:871-88. doi: 10.2147/COPD.S49621. eCollection 2014.

  PMID: 25210449 BACKGROUND

• Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006 Feb;27(2):397-412. doi: 10.1183/09031936.06.00025805. No abstract available.

  PMID: 16452599 BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Sidra Faisal, MS.CPPT

  Riphah International University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Iqbal Tariq, PHD

CONTACT

O3338236752; iqbal.tariq@riphah.edu.pk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Masking Details: Group A 20 participants received Buyteko breathing technique while Group B 20 participants received active cycle of breathing technique and session of 35min will be given 5 days per week and data will be collected by using St. George's respiratory questionnaire for determining the quality of life and Borg's dyspnea scale for measuring breathlessness. participant and investigator are blind
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: make 2 groups Patients who will meet the inclusion criteria will be recruited by convenient sampling technique and allocated in two groups by simple randomization process. First Group A 20 participants received Buyteko breathing technique while Group B 20 participants received active cycle of breathing technique and session of 35min will be given 5 days per week and data will be collected by using St. George's respiratory questionnaire for determining the quality of life and Borg's dyspnea scale for measuring breathlessness.

Study Record Dates

• First Submitted: June 14, 2023
• First Posted: July 17, 2023
• Study Start: May 15, 2023
• Primary Completion: October 10, 2023
• Study Completion: December 15, 2023
• Last Updated: July 17, 2023

Record last verified: 2023-07

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)